Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Migraine Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Migraine Drugsmarket, defines the market attractiveness level of Anti-Migraine Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Migraine Drugs industry, describes the types of Anti-Migraine Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Migraine Drugs market and the development prospects and opportunities of Anti-Migraine Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Migraine Drugs market in Chapter 13.
By Player:
Pfizer
Endo
Teva
Johnson and Johnson
Allergan
AstraZeneca
Merck
GlaxoSmithKline
Eisai
Abbott Laboratories
Bayer
Impax Laboratories
Eli Lilly
Amgen
By Type:
Triptans
Ergots
Others
By End-User:
Women
Men
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Migraine Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Migraine Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Migraine Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Migraine Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Migraine Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti-Migraine Drugs Consumption (2017-2022)
-
7.2 United States Anti-Migraine Drugs Consumption (2017-2022)
-
7.3 Europe Anti-Migraine Drugs Consumption (2017-2022)
-
7.4 China Anti-Migraine Drugs Consumption (2017-2022)
-
7.5 Japan Anti-Migraine Drugs Consumption (2017-2022)
-
7.6 India Anti-Migraine Drugs Consumption (2017-2022)
-
7.7 South Korea Anti-Migraine Drugs Consumption (2017-2022)
8 Region and Country-wise Anti-Migraine Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti-Migraine Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti-Migraine Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Migraine Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti-Migraine Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Migraine Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti-Migraine Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Migraine Drugs Consumption Forecast (2022-2028)
9 Global Anti-Migraine Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Migraine Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Triptans Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ergots Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Migraine Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Women Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Men Consumption and Growth Rate (2017-2022)
10 Global Anti-Migraine Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Migraine Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Triptans Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ergots Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Migraine Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Women Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Men Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Migraine Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Migraine Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Migraine Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Migraine Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Migraine Drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Anti-Migraine Drugs Product and Service
-
14.2 Endo
-
14.2.1 Endo Company Details
-
14.2.2 Endo Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Endo Anti-Migraine Drugs Product and Service
-
14.3 Teva
-
14.3.1 Teva Company Details
-
14.3.2 Teva Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Anti-Migraine Drugs Product and Service
-
14.4 Johnson and Johnson
-
14.4.1 Johnson and Johnson Company Details
-
14.4.2 Johnson and Johnson Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson and Johnson Anti-Migraine Drugs Product and Service
-
14.5 Allergan
-
14.5.1 Allergan Company Details
-
14.5.2 Allergan Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan Anti-Migraine Drugs Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Anti-Migraine Drugs Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Anti-Migraine Drugs Product and Service
-
14.8 GlaxoSmithKline
-
14.8.1 GlaxoSmithKline Company Details
-
14.8.2 GlaxoSmithKline Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Anti-Migraine Drugs Product and Service
-
14.9 Eisai
-
14.9.1 Eisai Company Details
-
14.9.2 Eisai Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eisai Anti-Migraine Drugs Product and Service
-
14.10 Abbott Laboratories
-
14.10.1 Abbott Laboratories Company Details
-
14.10.2 Abbott Laboratories Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Laboratories Anti-Migraine Drugs Product and Service
-
14.11 Bayer
-
14.11.1 Bayer Company Details
-
14.11.2 Bayer Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer Anti-Migraine Drugs Product and Service
-
14.12 Impax Laboratories
-
14.12.1 Impax Laboratories Company Details
-
14.12.2 Impax Laboratories Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Impax Laboratories Anti-Migraine Drugs Product and Service
-
14.13 Eli Lilly
-
14.13.1 Eli Lilly Company Details
-
14.13.2 Eli Lilly Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Eli Lilly Anti-Migraine Drugs Product and Service
-
14.14 Amgen
-
14.14.1 Amgen Company Details
-
14.14.2 Amgen Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Amgen Anti-Migraine Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Migraine Drugs
-
Figure Anti-Migraine Drugs Picture
-
Table Global Anti-Migraine Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Migraine Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Migraine Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Migraine Drugs Consumption by Country (2017-2022)
-
Figure United States Anti-Migraine Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Migraine Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Migraine Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Migraine Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Migraine Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Migraine Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Migraine Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Triptans Consumption and Growth Rate (2017-2022)
-
Figure Global Ergots Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Women Consumption and Growth Rate (2017-2022)
-
Figure Global Men Consumption and Growth Rate (2017-2022)
-
Figure Global Triptans Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ergots Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Women Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Men Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Migraine Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Migraine Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-Migraine Drugs Product and Service
-
Table Endo (Foundation Year, Company Profile and etc.)
-
Table Endo Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Anti-Migraine Drugs Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Anti-Migraine Drugs Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Anti-Migraine Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Anti-Migraine Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anti-Migraine Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti-Migraine Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti-Migraine Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Anti-Migraine Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Anti-Migraine Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Anti-Migraine Drugs Product and Service
-
Table Impax Laboratories (Foundation Year, Company Profile and etc.)
-
Table Impax Laboratories Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Impax Laboratories Anti-Migraine Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Anti-Migraine Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Anti-Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Anti-Migraine Drugs Product and Service
-
